XML 20 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Shareholders Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning balance at Dec. 31, 2018 $ 10,604.7 $ 3.8 $ 985.9 $ 11,064.7 $ (1,657.1) $ 207.4
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2018   385,500,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) 79.1     (102.3) 179.2 2.2
Stock Issued During Period, Shares, Restricted Stock Award, Gross   400,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (5.1)   (5.1)      
Stock based compensation 22.1   22.1      
Dividends (18.8)     (18.8)    
Dividends for noncontrolling interests (0.3)         (0.3)
Ending balance at Jun. 30, 2019 10,682.3 $ 3.8 1,002.9 10,944.2 (1,477.9) 209.3
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2019   385,900,000        
Beginning balance at Mar. 31, 2019 10,807.5 $ 3.8 996.2 11,196.8 (1,595.6) 206.3
Common stock shares outstanding, beginning balance (in shares) at Mar. 31, 2019   385,800,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) (112.2)     (233.1) 117.7 3.2
Stock Issued During Period, Shares, Restricted Stock Award, Gross   100,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (0.1)   (0.1)      
Stock based compensation 6.8   6.8      
Dividends (19.5)     (19.5)    
Dividends for noncontrolling interests (0.2)         (0.2)
Ending balance at Jun. 30, 2019 10,682.3 $ 3.8 1,002.9 10,944.2 (1,477.9) 209.3
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2019   385,900,000        
Beginning balance at Dec. 31, 2019 $ 9,367.6 $ 3.8 858.4 9,921.5 (1,598.2) 182.1
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2019 378,764,442 378,800,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) $ (681.7)     (155.6) (515.0) (11.1)
Stock Issued During Period, Shares, Restricted Stock Award, Gross   300,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (2.7)   (2.7)      
Stock based compensation (0.3)   (0.3)      
Dividends (18.9)     (18.9)    
Dividends for noncontrolling interests (0.3)         (0.3)
Ending balance at Jun. 30, 2020 $ 8,663.7 $ 3.8 855.4 9,747.0 (2,113.2) 170.7
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2020 379,090,013 379,100,000        
Beginning balance at Mar. 31, 2020 $ 8,559.9 $ 3.8 847.7 9,718.7 (2,184.0) 173.7
Common stock shares outstanding, beginning balance (in shares) at Mar. 31, 2020   379,000,000.0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) 115.4     47.4 70.8 (2.8)
Stock Issued During Period, Shares, Restricted Stock Award, Gross   100,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (0.3)   (0.3)      
Stock based compensation 8.0   8.0      
Dividends (19.1)     (19.1)    
Dividends for noncontrolling interests (0.2)         (0.2)
Ending balance at Jun. 30, 2020 $ 8,663.7 $ 3.8 $ 855.4 $ 9,747.0 $ (2,113.2) $ 170.7
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2020 379,090,013 379,100,000